Live feed
Filing
SC 13D/A
SC 13D/A0000920465-20-000115·LA JOLLA PHARMACEUTICAL CO
Schedule 13D ownership disclosure
TETRAPHASE PHARMA
Security class unavailable · CUSIP: 88165N204
Event date: 2020-06-29
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,085,000
- Percent of class
- 14.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000920465-20-000115
- Form type
- SC 13D/A
- Filer
- LA JOLLA PHARMACEUTICAL CO
- CIK
- CIK 920465
- Filed
- Jul 01, 2020
- Reporting period
- Jun 29, 2020
- Description
- Schedule 13D beneficial ownership